A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ASA / arylsulfatase A

[Related PubMed/MEDLINE]
Total Number of Papers: 219
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ASA  (>> Co-occurring Abbreviation)
Long Form:   arylsulfatase A
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 AAT, ACP, CTSD, CWI, IL-10, IL-1beta, IL-6, IL-8, TGF-beta1, TNF-alpha
2022 Long-Term Consequences of Increased Activity of Urine Enzymes After Cardiac Surgery - A Prospective Observational Study. AKI, CABG, CS, CSA-AKI, NAG
2022 [Lysosomal enzyme analysis of mucolipidosis type II α/β and type III α/β in two Chinese pedigrees]. GBA, GLA, GLB1, GUSB, IDUA, ML, NAGLU
2021 Deletion of fatty acid amide hydrolase reduces lyso-sulfatide levels but exacerbates metachromatic leukodystrophy in mice. FAAH, MLD
2021 Novel disease-causing variants in a cohort of Iranian patients with metachromatic leukodystrophy and in silico analysis of their pathogenicity. MLD
2021 The Effect of Submaximal Exercise Followed by Short-Term Cold-Water Immersion on the Inflammatory State in Healthy Recreational Athletes: A Cross-Over Study. AAT, ACP, CTSD, CWI, IL-10, IL-6, TGF-beta1, TNF-alpha
2020 Arylsulfatase A (ASA) in Parkinson's Disease: From Pathogenesis to Biomarker Potential. MLD, PD, SNCA
2020 Arylsulfatase A pseudodeficiency in Mexico: Enzymatic activity and haplotype analysis. ---
2020 Brain cell type-specific endocytosis of arylsulfatase A identifies limitations of enzyme-based therapies for metachromatic leukodystrophy. ---
10  2020 Comprehensive clinical, biochemical, radiological and genetic analysis of 28 Turkish cases with suspected metachromatic leukodystrophy and their relatives. MLD, PD
11  2020 Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1/2 study. MLD
12  2020 Metachromatic leukodystrophy genotypes in The Netherlands reveal novel pathogenic ARSA variants in non-Caucasian patients. MLD
13  2020 River water irrigation with heavy metal load influences soil biological activities and risk factors. Er, FDA, MBC, NRA, PMN, RI, UA
14  2020 Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trial. CSF, EOW, MLD, SAEs
15  2020 The Impact of Modern Therapeutic Methods on the Oxidant-Antioxidant Equilibrium and Activities of Selected Lysosomal Enzymes and Serine Protease Inhibitor in Amateur Athletes. AAT, ACP, CAT, CTSD, DEMS, GPx, SOD, TBARS, US
16  2019 Metachromatic leukodystrophy: Characterization of two (p.Leu433Val, p.Gly449Arg) arylsulfatase A mutations. MLD
17  2019 Pharmacokinetic Modeling of Intrathecally Administered Recombinant Human Arylsulfatase A (TAK-611) in Children With Metachromatic Leukodystrophy. CNS, CSF, MLD, PK
18  2019 The impact of high-intensity laser therapy on oxidative stress, lysosomal enzymes, and protease inhibitor in athletes. AAT, ACP, CAT, CTSD, GPx, HILT, SOD
19  2017 Activity of urine arylsulfatase A in brain‑dead graft donors is a predictor of early and late graft function. ---
20  2017 Potential of surfactant-coated nanoparticles to improve brain delivery of arylsulfatase A. BBB, CNS, ERT, LSD, MLD
21  2016 Metachromatic leukodystrophy: Biochemical characterization of two (p.307Glu→Lys, p.318Trp→Cys) arylsulfatase A mutations. CHO, MLD
22  2016 The oxidant-antioxidant equilibrium, activities of selected lysosomal enzymes and activity of acute phase protein in peripheral blood of 18-year-old football players after aerobic cycle ergometer test combined with ice-water immersion or recovery at room temperature. AAT, ACP, CAT, CTSD, GPx, SOD
23  2015 Activity of alpha1-antitrypsin and some lysosomal enzymes in the blood serum of patients with chronic obstructive pulmonary disease after smoking cessation. AAT, ACP, CTSD
24  2015 Determination of arylsulfatase A pseudodeficiency allele and haplotype frequency in the Tunisian population. ASA-PD, LD, MLD
25  2015 Dysfunction of platelet-derived growth factor receptor alpha (PDGFRalpha) represses the production of oligodendrocytes from arylsulfatase A-deficient multipotential neural precursor cells. NPs, OLs, PDGFRalpha
26  2015 Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy. CNS, CRIM, CSF, MLD, NCS, SSEPs
27  2014 Arylsulfatase A bound to poly(butyl cyanoacrylate) nanoparticles for enzyme replacement therapy--physicochemical evaluation. MLD, PBCA
28  2014 Comparison of five peptide vectors for improved brain delivery of the lysosomal enzyme arylsulfatase A. apoB, BBB, ERT, LSDs, Tat
29  2014 Long-term correction of biochemical and neurological abnormalities in MLD mice model by neonatal systemic injection of an AAV serotype 9 vector. BBB, GFP, LSD, MLD, SC, ssAAV9, Sulf
30  2013 Developing therapeutic approaches for metachromatic leukodystrophy. BBB, MLD
31  2013 Effects of open versus laparoscopic nephrectomy techniques on oxidative stress markers in patients with renal cell carcinoma. ACP, CAT, CTSD, GPx, SOD, TBARS
32  2013 Fluorescent dye conjugates of rabbit arylsulfatase A as a biological tracer for protein endocytosis. ---
33  2012 Brain MRI and biological diagnosis in five Tunisians MLD patients. MLD, MRI
34  2012 Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age. ERT, HSCT, MLD, NCV
35  2012 Novel patient cell-based HTS assay for identification of small molecules for a lysosomal storage disease. HTS, LSDs, MLD, pNC, pNCS, SV40t
36  2012 Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor. BBB, HIR, mAb, MLD
37  2012 Sperm arylsulfatase A binds to mZP2 and mZP3 glycoproteins in a nonenzymatic manner. ZP
38  2011 Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression. ASA-PD, EDSS, MLD, MR, MS, MSSS
39  2011 Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy. BBB, CNS, CSF, ERT, LSD, MLD, rhASA
40  2011 Transport of arylsulfatase A across the blood-brain barrier in vitro. BBB
41  2010 Metachromatic leukodystrophy--an update. MLD
42  2010 Nitrogen fixation capacity of Azotobacter spp. strains isolated from soils in different ecosystems and relationship between them and the microbiological properties of soils. APA, BSR, CA, GA, UA
43  2009 Automatic analysis of altered gait in arylsulphatase A-deficient mice in the open field. ---
44  2009 Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy. CNS, ERT, LSDs, MLD, PNS, rhASA
45  2009 Global diffuse distribution in the brain and efficient gene delivery to the dorsal root ganglia by intrathecal injection of adeno-associated viral vector serotype 1. AAV1, GFP, i.t, MLD
46  2009 Interaction of arylsulfatase-A (ASA) with its natural sulfoglycolipid substrates: a computational and site-directed mutagenesis study. SGC, SGG
47  2009 Saposin B-dependent reconstitution of arylsulfatase A activity in vitro and in cell culture models of metachromatic leukodystrophy. SapB
48  2009 Site-specific analysis of N-linked oligosaccharides of recombinant lysosomal arylsulfatase A produced in different cell lines. ERT, MLD
49  2008 Early signs of neurolipidosis-related behavioural alterations in a murine model of metachromatic leukodystrophy. MLD
50  2008 Mannose 6-phosphate receptor-dependent endocytosis of lysosomal enzymes is increased in sulfatide-storing kidney cells. ---
51  2008 Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options. ---
52  2008 Presence of arylsulfatase A and sulfogalactosylglycerolipid in mouse ovaries: localization to the corpus luteum. SGG
53  2008 Sulfatide is required for efficient replication of influenza A virus. CGT, CST, HA, IAVs, mAb, NP
54  2007 A spontaneously immortalized Schwann cell line to study the molecular aspects of metachromatic leukodystrophy. MLD
55  2007 Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy. MLD
56  2007 Induction of tolerance to human arylsulfatase A in a mouse model of metachromatic leukodystrophy. ERT, hASA, MLD
57  2007 Serum adenosine deaminase and arylsulphatase A as an index of early infiltration of central nervous system in acute lymphoblastic leukemia. ADA, ALL, CNS
58  2007 Sperm surface arylsulfatase A can disperse the cumulus matrix of cumulus oocyte complexes. COCs
59  2007 Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy. CST
60  2007 Sulfogalactosylceramides in motor and psycho-cognitive adult metachromatic leukodystrophy: relations between clinical, biochemical analysis and molecular aspects. MLD, MS
61  2007 The effect of whole-body cryostimulation on lysosomal enzyme activity in kayakers during training. ACP, CK, CTSD
62  2007 The effects of heavy metal pollution on enzyme activities and basal soil respiration of roadside soils. APA, BSR, UA
63  2006 AAV1 mediated co-expression of formylglycine-generating enzyme and arylsulfatase a efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy. AAV1, FGE, MLD
64  2006 Carbohydrate affinity chromatography indicates that arylsulfatase-A from capacitated boar sperm has mannose and N-acetylglucosamine/sialic acid residues. Con A, RP
65  2006 Ethanol decreases rat hepatic arylsulfatase A activity levels. ---
66  2006 Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres. HIV-ASA, MLD
67  2006 In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients. GMP, M6P, MSCs
68  2006 Late-onset metachromatic leukodystrophy: genotype strongly influences phenotype. ---
69  2006 Modest phenotypic improvements in ASA-deficient mice with only one UDP-galactose:ceramide-galactosyltransferase gene. ---
70  2006 Reduced brain cholesterol content in arylsulfatase A-deficient mice. MLD
71  2006 Steroid sulfatase, arylsulfatases A and B, galactose-6-sulfatase, and iduronate sulfatase in mammary cells and effects of sulfated and non-sulfated estrogens on sulfatase activity. ASB, GAGs, IDS, STS
72  2006 Sulfatide with short fatty acid dominates in astrocytes and neurons. ---
73  2006 Tyrosine sulfation of arylsulfatase A and its peptide. ---
74  2005 A novel mass spectrometric assay for the cerebroside sulfate activator protein (saposin B) and arylsulfatase A. ---
75  2005 Changes of lysosomal enzymes activity in the skeletal muscle fibers exposed to endurance exercise. beta-GRS, NAG
76  2005 Coexpression of formylglycine-generating enzyme is essential for synthesis and secretion of functional arylsulfatase A in a mouse model of metachromatic leukodystrophy. FGE, MLD
77  2005 Delay of myelin formation in arylsulphatase A-deficient mice. MBP, MLD, PLP
78  2005 Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy. ERT, PNS
79  2005 Evaluation of leukocyte arylsulphatase a, serum interleukin-6 and urinary heparan sulphate following tamoxifen therapy in breast cancer. GAGs, HS, HSPGs, IL-6, TAM
80  2005 Gene therapy of metachromatic leukodystrophy. MLD
81  2005 Human chronic fascioliasis: a possible cause of unexplained abnormal liver tests. ACP, ALP, AST, GGT, IHAT
82  2005 Missense mutations as a cause of metachromatic leukodystrophy. Degradation of arylsulfatase A in the endoplasmic reticulum. ER
83  2005 Peripheral neuropathy in metachromatic leucodystrophy. A study of 40 cases from south India. MLD
84  2004 Accumulation of sulfatide in neuronal and glial cells of arylsulfatase A deficient mice. ---
85  2004 ASA E382K disrupts a potential exonic splicing enhancer and causes exon skipping, but missense mutations in ASA are not associated with ESEs. ESE, MLD
86  2004 Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-alpha, and leukocyte arylsulfatase-A activity in patients with bladder cancer. IL-8, MIBC, SBC, TNF-alpha
87  2004 Late onset MLD with normal nerve conduction associated with two novel missense mutations in the ASA gene. MLD
88  2004 Lysosomal sulfatide storage in the brain of arylsulfatase A-deficient mice: cellular alterations and topographic distribution. ---
89  2004 Novel mutations associated with metachromatic leukodystrophy: phenotype and expression studies in nine Czech and Slovak patients. MLD
90  2004 Rat sperm AS-A: subcellular localization in testis and epididymis and surface distribution in epididymal sperm. Cd, Co, Cp, ER, IS
91  2004 [Relationship between mycoplasma infection and germ cell sulfogalactosylglycerolipid]. SGG, UU
92  2003 Acquisition of arylsulfatase A onto the mouse sperm surface during epididymal transit. ---
93  2003 Disease-causing mutations in cis with the common arylsulfatase A pseudodeficiency allele compound the difficulties in accurately identifying patients and carriers of metachromatic leukodystrophy. MLD, PD
94  2002 Adult metachromatic leukodystrophy: three cases with normal nerve conduction velocities in a family. MLD, MRI
95  2002 Allelic variation and environmental lead exposure in urban children. ---
96  2002 Arylsulfatase a is present on the pig sperm surface and is involved in sperm-zona pellucida binding. ZP
97  2002 Binding of arylsulfatase A to mouse sperm inhibits gamete interaction and induces the acrosome reaction. Ig, SGG
98  2002 Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations. MLD
99  2002 Croatian population data for arylsulfatase a pseudodeficiency-associated mutations in healthy subjects, and in patients with Alzheimer-type dementia and Down syndrome. ---
100  2002 Defective oligomerization of arylsulfatase a as a cause of its instability in lysosomes and metachromatic leukodystrophy. ---